Effect of recombinant human interleukin-11 on motilin and substance P release in normal and inflamed rabbits

Regulatory Peptides

Volumn 97, Issue 2-3, 2001, Pages 111-119

  Depoortere, Inge ^a   Thijs, Theo ^a   Thielemans, Leen ^a   Keith, James C ^b   Van Assche, Gert ^a   Peeters, Theo L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b PFIZER INC   (United States)

Author keywords

Colitis; Expression; Hormone level; Interleukin; Neuropeptides

Indexed keywords

MESSENGER RNA; MOTILIN; NEUROPEPTIDE; RECOMBINANT INTERLEUKIN 11; SUBSTANCE P; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DIGESTIVE SYSTEM INFLAMMATION; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; TISSUE LEVEL;

ANIMALS; BASE SEQUENCE; COLITIS; DNA PRIMERS; FEMALE; HUMANS; INTERLEUKIN-11; INTESTINAL MUCOSA; MALE; MOTILIN; RABBITS; RECOMBINANT PROTEINS; RNA, MESSENGER; SUBSTANCE P;

ORYCTOLAGUS CUNICULUS;

EID: 0035794037     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00190-7     Document Type: Article

References (43)

1. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine
2. Interleukin-11: Review of molecular, cell biology, and clinical use
3. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease
4. Dose-dependent effects of interleukin-11 on contractile parameters in rabbit TNBS-colitis
5. Gut hormones in inflammatory bowel disease
6. Gastrin, secretin, VIP and motilin in children with mucoviscidosis and Crohn disease
7. Gut hormone responses after reconstructive surgery for ulcerative colitis
8. DNA polymorphism in the human motilin gene in inflammatory bowel disease
9. Gall stones in Crohn's disease: Another hypothesis
10. Gastrointestinal motility disorders in patients with inactive Crohn's disease
11. Inverse regulation of motilin and motilin receptors in inflamed and non-inflamed areas during TNBS-induced colitis in rabbits
12. Sensory neuropeptides: Their role in inflammation and wound healing
13. +)-induced contractility in rabbit colitis
14. In man, only activity fronts that originate in the stomach correlate with motilin peaks
15. The isolation and characterization of rabbit motilin precursor cDNA
16. Sequence of the rabbit glyceraldehyde-3-phosphate dehydrogenase-encoding cDNA
17. Downregulation of neutral endopeptidase (EC3.4.24.11) in the inflamed rat intestine
18. Polymorphism of motilin gene in patients with Crohn's disease
19. Identification of motilin mRNA in the brain of man and rabbit. Conservation of polymorphism of the motilin gene across species
20. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data
21. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms
22. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB
23. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions
24. Distribution and quantification of gut neuropeptides in normal intestine and in inflammatory bowel disease
25. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease
26. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease
27. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis
28. Peptide-containing nerve fibers in the gut wall in Crohn's disease
29. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease
30. Increased levels of substance P in the myenteric plexus of Trichinella-infected rats
31. Substance P levels in experimental ileitis in guinea pigs: Effects of misoprostol
32. Regional content of enteric substance P and vasoactive intestinal peptide during intestinal inflammation in the parasitized ferret
33. Substance P gene expression in acute experimental colitis
34. Protective function of extrinsic sensory neurons in acute rabbit experimental colitis
35. Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons
36. Interleukin 1 beta-induced increase in substance P in rat myenteric plexus
37. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed
38. Gastric emptying in childhood inflammatory bowel disease: Nutritional and pathologic correlates
39. Gallbladder hypokinesia in Crohn's disease
40. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease
41. Tachykinergic neurotransmission is enhanced in small intestinal circular muscle in a rabbit model of inflammation
42. A novel motility effect of tachykinins in normal and inflamed colon
43. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat